AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
It should include exact sequences, chemical forms, component-specific identity and quantity, measured ratio, chromatograms, batch details and test limitations
B12/MIC should be used in combination with diet and exercise to maximize results
Predrag Sikiric's research group at the University of Zagreb, Croatia, beginning in the early 1990s
Because of its ability to enhance recovery and reduce pain, the TB 500 peptide is becoming popular in regenerative medicine, sports therapy, and medical aesthetics